I
0.247
0.02 (8.33%)
| 前收盘价格 | 0.228 |
| 收盘价格 | 0.232 |
| 成交量 | 25,880,000 |
| 平均成交量 (3个月) | 4,309,752 |
| 市值 | 455,902,720 |
| 价格/销量 (P/S) | 363.76 |
| 52周波幅 | |
| 利润日期 | 29 Nov 2024 |
| 营业利益率 (TTM) | 657.78% |
| 稀释每股收益 (EPS TTM) | -0.010 |
| 季度收入增长率 (YOY) | -18.70% |
| 季度盈利增长率 (YOY) | -47.50% |
| 总债务/股东权益 (D/E MRQ) | 4,140.48% |
| 流动比率 (MRQ) | 0.010 |
| 营业现金流 (OCF TTM) | -6.53 M |
| 杠杆自由现金流 (LFCF TTM) | -128.15 M |
| 资产报酬率 (ROA TTM) | -0.67% |
| 股东权益报酬率 (ROE TTM) | -330.85% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Specialty Retail (HK) | 混合的 | 混合的 |
| Specialty Retail (全球的) | 看涨 | 混合的 | |
| 股票 | INNOVATIVE PHAR | - | - |
AIStockmoo 评分
-0.5
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 1.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.50 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| INNOVATIVE PHAR | 456 M | - | - | - |
| QIDIAN GUOFENG | 6 B | - | - | 43.54 |
| SA SA INT'L | 2 B | 4.17% | 30.50 | 1.69 |
| GOME RETAIL | 925 M | - | - | 0.210 |
| IH RETAIL | 660 M | 10.67% | 7.67 | 0.690 |
| MI MING MART | 148 M | 8.89% | - | 1.52 |
|
Innovative Pharmaceutical Biotech Ltd is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The company has two operating segments; Trading of beauty products in Hong Kong and Research, development, and commercialisation of the oral insulin product. The company generates almost all of its revenue from Hong Kong. |
|
| 部门 | Consumer Cyclical |
| 行业 | Specialty Retail |
| 投资方式 | Small Value |
| 内部持股比例 | 42.28% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合